VSTM

6.3307.73%
MJ

Michelle J. Robertson

EVP, CFO, Treasurer and Principal Financial & Accounting Officer

Ms. Michelle J. Robertson serves as Executive Vice President, Chief Financial Officer, Treasurer and principal financial & accounting officer at Geron Corporation since September 25, 2023 and served as its Interim Secretary. She served as Chief Financial Officer, Principal Accounting Officer, Treasurer and Assistant Secretary at Editas Medicine, Inc., since January 09, 2020 until May 17, 2023 and remained in an advisory role through August 16, 2023, to ensure a smooth transition. She also had served as Executive Vice President at Editas Medicine, Inc. since March 2022 until 2022. She has been an Independent Director of Verastem Inc. since November 15, 2021. She served as Principal Financial Officer, Principal Accounting Officer, Chief Financial Officer, Treasurer and Senior Vice President at Momenta Pharmaceuticals, Inc. since October 5, 2018 until January 8, 2020. Ms. Robertson has biotech finance and commercial operations management experience. Ms. Robertson served as Vice President of Financial Planning and Analysis at Momenta Pharmaceuticals, Inc. since May 2017 until October 5, 2018. Ms. Robertson joined Momenta in May 2017 and has served as Vice President, Financial Planning and Analysis during such time. Prior to joining Momenta, she served as Vice President, Oncology Finance at Baxalta, Inc., from 2015 to 2017 a biopharmaceutical company, following its spin-off from Baxter International, from 2015 to 2016. She served as Head of Financial Planning and Analysis and Operations Excellence at Ironwood Pharmaceuticals, a pharmaceutical company, from 2012 to 2015. Ms. Robertson joined Genzyme (now Sanofi Genzyme) Corporation in 1995 and served in various leadership positions in its Oncology and Biosurgery divisions of Finance and Commercial Operations until 2011. Ms. Robertson received her B.S. in Finance and A.S. in Accounting and Management from Bentley University.

公司职务